查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1872340

灌注式生物反應器：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Perfusion Bioreactors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球灌註生物反應器市場規模估計為 7.03 億美元，預計到 2031 年將達到 11.53 億美元，在預測期（2025-2031 年）內複合年成長率為 7.2%。

本報告對近期與灌註生物反應器相關的關稅調整和國際戰略反制措施進行了全面評估，包括其對跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響。

灌流是一種維持細胞培養生物反應器的方法，在這種方法中，等體積的培養基被添加到反應器中，並從反應器中移除，同時將細胞保持在反應器內。與傳統的補料批次生物反應器相比，灌流生物反應器在可擴展性和滿足日益成長的需求方面具有許多優勢。灌流生物反應器透過持續供應新鮮培養基和移除廢培養基，可實現長達數月的長期培養，同時保持細胞在培養中存活。在灌流過程中，有多種方法可以實現維持細胞培養和移除廢培養基。

全球主要的灌註生物反應器生產商包括賽多利斯（Sartorius AG）、賽特瓦（Cytiva）、賽默飛世爾（Thermo Fisher）、愛本多（Eppendorf AG）和ZETA）。排名前五的全球生產商佔據了超過79%的市場。目前，北美是全球最大的灌註生物反應器市場，佔超過40%的市場佔有率，其次是亞太地區和歐洲市場，這兩個地區合計佔超過40%的市場佔有率。

灌注式生物反應器市場的主要促進因素包括：

生物製藥產業的快速發展

隨著人們健康意識的增強，對生物製藥產品的需求持續成長。生物製藥產業的快速發展是灌注式生物反應器的主要應用領域之一，直接推動了市場對灌注式生物反應器的需求。在研發和生產過程中，生物製藥企業需要高效穩定的生物反應器來支持細胞培養、病毒擴增等關鍵工藝，而灌注式生物反應器正是滿足這些需求的重要工具。

生物技術的持續進步

生物技術的快速發展為灌注式生物反應器帶來了更多應用和可能性。隨著新型細胞培養、生物合成和基因編輯技術的出現，灌注式生物反應器的功能日益多樣化，使其能夠滿足更多種類生物製藥和生物技術產品的生產需求。此外，生物技術的進步也推動著灌注式生物反應器技術的持續創新和完善，從而不斷提高其生產效率和性能。

政府政策支持

世界各國政府紛紛推出政策，促進生物製藥和生技產業的發展。這些政策不僅為生物製藥企業提供財政支持和稅收優惠等扶持措施，也促進相關產業鏈的建設和改善。在這些政策的推動下，生物製藥和生技產業迅速發展，進而帶動了灌注式生物反應器市場的成長。

市場競爭與技術創新

全球灌流式生物反應器市場競爭激烈，主要企業積極研發新產品、開拓新市場。這種市場競爭促進了灌注式生物反應器技術的持續創新和進步，從而提升了產品的性能和品質。同時，公司間的合作與併購也加速了該技術的推廣與應用，進一步推動了市場成長。

新興市場機遇

隨著生物相似藥和基因編輯等新興領域的快速發展，灌注式生物反應器有望在這些領域中廣泛應用。這些新興市場為灌注式生物反應器提供了新的發展機會和成長空間。例如，在生物相似藥領域，灌注式生物反應器可用於生產高品質的生物相似藥；在基因編輯領域，灌注式生物反應器可用於支持基因編輯細胞的增殖和分化等過程。

摘要，灌注式生物反應器市場的主要促進因素包括生物製藥產業的快速發展、生物技術的不斷進步、政府政策支援、市場競爭和技術創新以及新興市場機會。這些因素共同推動了灌注式生物反應器市場的快速成長和發展。

本報告旨在按地區/國家、類型和應用對全球灌註生物反應器市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

灌注式生物反應器市場規模、估算和預測以銷售量（千台）和收入（百萬美元）為單位呈現，基準年為2024年，並包含2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定灌注式生物反應器業務/成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Sartorius AG
  • Cytiva
  • Thermo Fisher
  • Eppendorf AG
  • ZETA
  • Infors HT
  • Applikon Biotechnology（Getinge）
  • Bioengineering AG
  • 3D Biotek
  • PBS Biotech, Inc.
  • Cell Culture Company
  • Zellwerk GmbH

按類型分類的細分市場

  • 小規模（小於100公升）
  • 中型（100-1000公升）
  • 大型（超過1000公升）

應用領域

  • 生物製藥
  • 生物技術
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Perfusion Bioreactors was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1153 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Perfusion Bioreactors cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor. Perfusion bioreactors offer several advantages over traditional fed-batch bioreactors when addressing problems of scalability and increasing demand. Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.

The main global perfusion bioreactor manufacturers include Sartorius AG,Cytiva,Thermo Fisher,Eppendorf AG and ZETA, etc. The top five global manufacturers account for more than 79% of the market share. Currently, North America is the world's largest perfusion bioreactor market, accounting for more than 40% of the market share, followed by the Asia-Pacific and European markets, which together account for more than 40% of the market share.

The driving factors of the perfusion bioreactor market mainly include the following:

The rapid development of the biopharmaceutical industry

As people pay more attention to health, the demand for biopharmaceutical products continues to grow. As one of the main application areas of perfusion bioreactors, the rapid development of the biopharmaceutical industry has directly promoted the market demand for perfusion bioreactors. In the process of research and development and production, biopharmaceutical companies need efficient and stable bioreactors to support key steps such as cell culture and virus amplification, and perfusion bioreactors are important tools to meet these needs.

Continuous progress in biotechnology

The rapid development of biotechnology has provided more application areas and possibilities for perfusion bioreactors. New cell culture technology, biosynthesis technology, and gene editing technology continue to emerge, making the functions of perfusion bioreactors more diversified and able to meet the production needs of more types of biopharmaceuticals and biotechnology products. In addition, the advancement of biotechnology has also promoted the continuous innovation and upgrading of perfusion bioreactor technology, improving its production efficiency and performance.

Support from government policies

Governments of various countries have introduced policies to encourage the development of biopharmaceutical and biotechnology industries. These policies not only provide biopharmaceutical companies with preferential measures such as financial support and tax incentives, but also promote the construction and improvement of related industrial chains. Driven by these policies, the biopharmaceutical and biotechnology industries have developed rapidly, which in turn has driven the growth of the perfusion bioreactor market.

Market competition and technological innovation

The global perfusion bioreactor market is highly competitive, and major companies are actively developing new products and expanding new markets. This market competition has promoted the continuous innovation and upgrading of perfusion bioreactor technology, improving the performance and quality of products. At the same time, cooperation and mergers and acquisitions between companies have also accelerated the dissemination and application of technology, further promoting market growth.

Emerging market opportunities

With the rapid development of emerging fields such as biosimilars and gene editing, perfusion bioreactors have broad application prospects in these fields. These emerging markets provide new development opportunities and growth space for perfusion bioreactors. For example, in the field of biosimilars, perfusion bioreactors can be used to produce high-quality biosimilars; in the field of gene editing, perfusion bioreactors can be used to support processes such as the expansion and differentiation of gene-edited cells.

In summary, the driving factors of the perfusion bioreactor market mainly include the rapid development of the biopharmaceutical industry, the continuous advancement of biotechnology, the support of government policies, market competition and technological innovation, and emerging market opportunities. These factors have jointly promoted the rapid growth and development of the perfusion bioreactor market.

This report aims to provide a comprehensive presentation of the global market for Perfusion Bioreactors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Perfusion Bioreactors by region & country, by Type, and by Application.

The Perfusion Bioreactors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perfusion Bioreactors.

Market Segmentation

By Company

  • Sartorius AG
  • Cytiva
  • Thermo Fisher
  • Eppendorf AG
  • ZETA
  • Infors HT
  • Applikon Biotechnology (Getinge)
  • Bioengineering AG
  • 3D Biotek
  • PBS Biotech, Inc.
  • Cell Culture Company
  • Zellwerk GmbH

Segment by Type

  • Small Scale (≤100 Liters)
  • Mid-Scale (100 to 1,000 Liters)
  • Large Scale (>1,000 Liters)

Segment by Application

  • Biopharmaceutical
  • Biotechnology
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Perfusion Bioreactors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Perfusion Bioreactors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Perfusion Bioreactors in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Perfusion Bioreactors Product Introduction
  • 1.2 Global Perfusion Bioreactors Market Size Forecast
    • 1.2.1 Global Perfusion Bioreactors Sales Value (2020-2031)
    • 1.2.2 Global Perfusion Bioreactors Sales Volume (2020-2031)
    • 1.2.3 Global Perfusion Bioreactors Sales Price (2020-2031)
  • 1.3 Perfusion Bioreactors Market Trends & Drivers
    • 1.3.1 Perfusion Bioreactors Industry Trends
    • 1.3.2 Perfusion Bioreactors Market Drivers & Opportunity
    • 1.3.3 Perfusion Bioreactors Market Challenges
    • 1.3.4 Perfusion Bioreactors Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Perfusion Bioreactors Players Revenue Ranking (2024)
  • 2.2 Global Perfusion Bioreactors Revenue by Company (2020-2025)
  • 2.3 Global Perfusion Bioreactors Players Sales Volume Ranking (2024)
  • 2.4 Global Perfusion Bioreactors Sales Volume by Company Players (2020-2025)
  • 2.5 Global Perfusion Bioreactors Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Perfusion Bioreactors Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Perfusion Bioreactors Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Perfusion Bioreactors
  • 2.9 Perfusion Bioreactors Market Competitive Analysis
    • 2.9.1 Perfusion Bioreactors Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Perfusion Bioreactors Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfusion Bioreactors as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Small Scale (<=100 Liters)
    • 3.1.2 Mid-Scale (100 to 1,000 Liters)
    • 3.1.3 Large Scale (>1,000 Liters)
  • 3.2 Global Perfusion Bioreactors Sales Value by Type
    • 3.2.1 Global Perfusion Bioreactors Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Perfusion Bioreactors Sales Value, by Type (2020-2031)
    • 3.2.3 Global Perfusion Bioreactors Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Perfusion Bioreactors Sales Volume by Type
    • 3.3.1 Global Perfusion Bioreactors Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Perfusion Bioreactors Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Perfusion Bioreactors Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Perfusion Bioreactors Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biopharmaceutical
    • 4.1.2 Biotechnology
    • 4.1.3 Others
  • 4.2 Global Perfusion Bioreactors Sales Value by Application
    • 4.2.1 Global Perfusion Bioreactors Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Perfusion Bioreactors Sales Value, by Application (2020-2031)
    • 4.2.3 Global Perfusion Bioreactors Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Perfusion Bioreactors Sales Volume by Application
    • 4.3.1 Global Perfusion Bioreactors Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Perfusion Bioreactors Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Perfusion Bioreactors Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Perfusion Bioreactors Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Perfusion Bioreactors Sales Value by Region
    • 5.1.1 Global Perfusion Bioreactors Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Perfusion Bioreactors Sales Value by Region (2020-2025)
    • 5.1.3 Global Perfusion Bioreactors Sales Value by Region (2026-2031)
    • 5.1.4 Global Perfusion Bioreactors Sales Value by Region (%), (2020-2031)
  • 5.2 Global Perfusion Bioreactors Sales Volume by Region
    • 5.2.1 Global Perfusion Bioreactors Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Perfusion Bioreactors Sales Volume by Region (2020-2025)
    • 5.2.3 Global Perfusion Bioreactors Sales Volume by Region (2026-2031)
    • 5.2.4 Global Perfusion Bioreactors Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Perfusion Bioreactors Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Perfusion Bioreactors Sales Value, 2020-2031
    • 5.4.2 North America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Perfusion Bioreactors Sales Value, 2020-2031
    • 5.5.2 Europe Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Perfusion Bioreactors Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Perfusion Bioreactors Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Perfusion Bioreactors Sales Value, 2020-2031
    • 5.7.2 South America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Perfusion Bioreactors Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Perfusion Bioreactors Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Perfusion Bioreactors Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Perfusion Bioreactors Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Perfusion Bioreactors Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Perfusion Bioreactors Sales Value, 2020-2031
    • 6.3.2 United States Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Perfusion Bioreactors Sales Value, 2020-2031
    • 6.4.2 Europe Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Perfusion Bioreactors Sales Value, 2020-2031
    • 6.5.2 China Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Perfusion Bioreactors Sales Value, 2020-2031
    • 6.6.2 Japan Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Perfusion Bioreactors Sales Value, 2020-2031
    • 6.7.2 South Korea Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Perfusion Bioreactors Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Perfusion Bioreactors Sales Value, 2020-2031
    • 6.9.2 India Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Perfusion Bioreactors Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Sartorius AG
    • 7.1.1 Sartorius AG Company Information
    • 7.1.2 Sartorius AG Introduction and Business Overview
    • 7.1.3 Sartorius AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Sartorius AG Perfusion Bioreactors Product Offerings
    • 7.1.5 Sartorius AG Recent Development
  • 7.2 Cytiva
    • 7.2.1 Cytiva Company Information
    • 7.2.2 Cytiva Introduction and Business Overview
    • 7.2.3 Cytiva Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Cytiva Perfusion Bioreactors Product Offerings
    • 7.2.5 Cytiva Recent Development
  • 7.3 Thermo Fisher
    • 7.3.1 Thermo Fisher Company Information
    • 7.3.2 Thermo Fisher Introduction and Business Overview
    • 7.3.3 Thermo Fisher Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Thermo Fisher Perfusion Bioreactors Product Offerings
    • 7.3.5 Thermo Fisher Recent Development
  • 7.4 Eppendorf AG
    • 7.4.1 Eppendorf AG Company Information
    • 7.4.2 Eppendorf AG Introduction and Business Overview
    • 7.4.3 Eppendorf AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Eppendorf AG Perfusion Bioreactors Product Offerings
    • 7.4.5 Eppendorf AG Recent Development
  • 7.5 ZETA
    • 7.5.1 ZETA Company Information
    • 7.5.2 ZETA Introduction and Business Overview
    • 7.5.3 ZETA Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 ZETA Perfusion Bioreactors Product Offerings
    • 7.5.5 ZETA Recent Development
  • 7.6 Infors HT
    • 7.6.1 Infors HT Company Information
    • 7.6.2 Infors HT Introduction and Business Overview
    • 7.6.3 Infors HT Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Infors HT Perfusion Bioreactors Product Offerings
    • 7.6.5 Infors HT Recent Development
  • 7.7 Applikon Biotechnology (Getinge)
    • 7.7.1 Applikon Biotechnology (Getinge) Company Information
    • 7.7.2 Applikon Biotechnology (Getinge) Introduction and Business Overview
    • 7.7.3 Applikon Biotechnology (Getinge) Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Applikon Biotechnology (Getinge) Perfusion Bioreactors Product Offerings
    • 7.7.5 Applikon Biotechnology (Getinge) Recent Development
  • 7.8 Bioengineering AG
    • 7.8.1 Bioengineering AG Company Information
    • 7.8.2 Bioengineering AG Introduction and Business Overview
    • 7.8.3 Bioengineering AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Bioengineering AG Perfusion Bioreactors Product Offerings
    • 7.8.5 Bioengineering AG Recent Development
  • 7.9 3D Biotek
    • 7.9.1 3D Biotek Company Information
    • 7.9.2 3D Biotek Introduction and Business Overview
    • 7.9.3 3D Biotek Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 3D Biotek Perfusion Bioreactors Product Offerings
    • 7.9.5 3D Biotek Recent Development
  • 7.10 PBS Biotech, Inc.
    • 7.10.1 PBS Biotech, Inc. Company Information
    • 7.10.2 PBS Biotech, Inc. Introduction and Business Overview
    • 7.10.3 PBS Biotech, Inc. Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 PBS Biotech, Inc. Perfusion Bioreactors Product Offerings
    • 7.10.5 PBS Biotech, Inc. Recent Development
  • 7.11 Cell Culture Company
    • 7.11.1 Cell Culture Company Company Information
    • 7.11.2 Cell Culture Company Introduction and Business Overview
    • 7.11.3 Cell Culture Company Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Cell Culture Company Perfusion Bioreactors Product Offerings
    • 7.11.5 Cell Culture Company Recent Development
  • 7.12 Zellwerk GmbH
    • 7.12.1 Zellwerk GmbH Company Information
    • 7.12.2 Zellwerk GmbH Introduction and Business Overview
    • 7.12.3 Zellwerk GmbH Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Zellwerk GmbH Perfusion Bioreactors Product Offerings
    • 7.12.5 Zellwerk GmbH Recent Development

8 Industry Chain Analysis

  • 8.1 Perfusion Bioreactors Industrial Chain
  • 8.2 Perfusion Bioreactors Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Perfusion Bioreactors Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Perfusion Bioreactors Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Perfusion Bioreactors Market Trends
  • Table 2. Perfusion Bioreactors Market Drivers & Opportunity
  • Table 3. Perfusion Bioreactors Market Challenges
  • Table 4. Perfusion Bioreactors Market Restraints
  • Table 5. Global Perfusion Bioreactors Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Perfusion Bioreactors Revenue Market Share by Company (2020-2025)
  • Table 7. Global Perfusion Bioreactors Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Perfusion Bioreactors Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Perfusion Bioreactors Price by Company (2020-2025) & (USD/Unit)
  • Table 10. Key Manufacturers Perfusion Bioreactors Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Perfusion Bioreactors Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Perfusion Bioreactors
  • Table 13. Global Perfusion Bioreactors Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfusion Bioreactors as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Perfusion Bioreactors Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Perfusion Bioreactors Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Perfusion Bioreactors Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Perfusion Bioreactors Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Perfusion Bioreactors Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Perfusion Bioreactors Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Perfusion Bioreactors Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Perfusion Bioreactors Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Perfusion Bioreactors Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Perfusion Bioreactors Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Perfusion Bioreactors Price by Type (2020-2025) & (USD/Unit)
  • Table 27. Global Perfusion Bioreactors Price by Type (2026-2031) & (USD/Unit)
  • Table 28. Global Perfusion Bioreactors Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Perfusion Bioreactors Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Perfusion Bioreactors Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Perfusion Bioreactors Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Perfusion Bioreactors Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Perfusion Bioreactors Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Perfusion Bioreactors Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Perfusion Bioreactors Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Perfusion Bioreactors Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Perfusion Bioreactors Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Perfusion Bioreactors Price by Application (2020-2025) & (USD/Unit)
  • Table 39. Global Perfusion Bioreactors Price by Application (2026-2031) & (USD/Unit)
  • Table 40. Global Perfusion Bioreactors Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Perfusion Bioreactors Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Perfusion Bioreactors Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Perfusion Bioreactors Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Perfusion Bioreactors Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Perfusion Bioreactors Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Perfusion Bioreactors Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Perfusion Bioreactors Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Perfusion Bioreactors Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Perfusion Bioreactors Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Perfusion Bioreactors Average Price by Region (2020-2025) & (USD/Unit)
  • Table 51. Global Perfusion Bioreactors Average Price by Region (2026-2031) & (USD/Unit)
  • Table 52. Key Countries/Regions Perfusion Bioreactors Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Perfusion Bioreactors Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Perfusion Bioreactors Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Perfusion Bioreactors Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Perfusion Bioreactors Sales Volume, (2026-2031) & (K Units)
  • Table 57. Sartorius AG Company Information
  • Table 58. Sartorius AG Introduction and Business Overview
  • Table 59. Sartorius AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 60. Sartorius AG Perfusion Bioreactors Product Offerings
  • Table 61. Sartorius AG Recent Development
  • Table 62. Cytiva Company Information
  • Table 63. Cytiva Introduction and Business Overview
  • Table 64. Cytiva Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 65. Cytiva Perfusion Bioreactors Product Offerings
  • Table 66. Cytiva Recent Development
  • Table 67. Thermo Fisher Company Information
  • Table 68. Thermo Fisher Introduction and Business Overview
  • Table 69. Thermo Fisher Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 70. Thermo Fisher Perfusion Bioreactors Product Offerings
  • Table 71. Thermo Fisher Recent Development
  • Table 72. Eppendorf AG Company Information
  • Table 73. Eppendorf AG Introduction and Business Overview
  • Table 74. Eppendorf AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 75. Eppendorf AG Perfusion Bioreactors Product Offerings
  • Table 76. Eppendorf AG Recent Development
  • Table 77. ZETA Company Information
  • Table 78. ZETA Introduction and Business Overview
  • Table 79. ZETA Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 80. ZETA Perfusion Bioreactors Product Offerings
  • Table 81. ZETA Recent Development
  • Table 82. Infors HT Company Information
  • Table 83. Infors HT Introduction and Business Overview
  • Table 84. Infors HT Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 85. Infors HT Perfusion Bioreactors Product Offerings
  • Table 86. Infors HT Recent Development
  • Table 87. Applikon Biotechnology (Getinge) Company Information
  • Table 88. Applikon Biotechnology (Getinge) Introduction and Business Overview
  • Table 89. Applikon Biotechnology (Getinge) Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 90. Applikon Biotechnology (Getinge) Perfusion Bioreactors Product Offerings
  • Table 91. Applikon Biotechnology (Getinge) Recent Development
  • Table 92. Bioengineering AG Company Information
  • Table 93. Bioengineering AG Introduction and Business Overview
  • Table 94. Bioengineering AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 95. Bioengineering AG Perfusion Bioreactors Product Offerings
  • Table 96. Bioengineering AG Recent Development
  • Table 97. 3D Biotek Company Information
  • Table 98. 3D Biotek Introduction and Business Overview
  • Table 99. 3D Biotek Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 100. 3D Biotek Perfusion Bioreactors Product Offerings
  • Table 101. 3D Biotek Recent Development
  • Table 102. PBS Biotech, Inc. Company Information
  • Table 103. PBS Biotech, Inc. Introduction and Business Overview
  • Table 104. PBS Biotech, Inc. Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 105. PBS Biotech, Inc. Perfusion Bioreactors Product Offerings
  • Table 106. PBS Biotech, Inc. Recent Development
  • Table 107. Cell Culture Company Company Information
  • Table 108. Cell Culture Company Introduction and Business Overview
  • Table 109. Cell Culture Company Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 110. Cell Culture Company Perfusion Bioreactors Product Offerings
  • Table 111. Cell Culture Company Recent Development
  • Table 112. Zellwerk GmbH Company Information
  • Table 113. Zellwerk GmbH Introduction and Business Overview
  • Table 114. Zellwerk GmbH Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 115. Zellwerk GmbH Perfusion Bioreactors Product Offerings
  • Table 116. Zellwerk GmbH Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Perfusion Bioreactors Downstream Customers
  • Table 120. Perfusion Bioreactors Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Perfusion Bioreactors Product Picture
  • Figure 2. Global Perfusion Bioreactors Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Perfusion Bioreactors Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Perfusion Bioreactors Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Perfusion Bioreactors Sales Price (2020-2031) & (USD/Unit)
  • Figure 6. Perfusion Bioreactors Report Years Considered
  • Figure 7. Global Perfusion Bioreactors Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Perfusion Bioreactors Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Perfusion Bioreactors Revenue in 2024
  • Figure 10. Perfusion Bioreactors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Small Scale (<=100 Liters) Picture
  • Figure 12. Mid-Scale (100 to 1,000 Liters) Picture
  • Figure 13. Large Scale (>1,000 Liters) Picture
  • Figure 14. Global Perfusion Bioreactors Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Perfusion Bioreactors Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Perfusion Bioreactors Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Perfusion Bioreactors Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Perfusion Bioreactors Price by Type (2020-2031) & (USD/Unit)
  • Figure 19. Product Picture of Biopharmaceutical
  • Figure 20. Product Picture of Biotechnology
  • Figure 21. Product Picture of Others
  • Figure 22. Global Perfusion Bioreactors Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Perfusion Bioreactors Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Perfusion Bioreactors Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 25. Global Perfusion Bioreactors Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Perfusion Bioreactors Price by Application (2020-2031) & (USD/Unit)
  • Figure 27. North America Perfusion Bioreactors Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Perfusion Bioreactors Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Perfusion Bioreactors Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Perfusion Bioreactors Sales Volume (%), (2020-2031)
  • Figure 39. United States Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Perfusion Bioreactors Industrial Chain
  • Figure 61. Perfusion Bioreactors Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed